Wormentel Duo (Ivermectin + Albendazole): The Combination Antiparasitic Explained

What Wormentel Duo Actually Contains

Each Wormentel Duo 156mg tablet manufactured by Kachhela Medex contains ivermectin (typically 6mg) and albendazole (typically 400mg) in a single fixed-dose combination. This aligns with the reference combination doses studied in WHO and academic clinical trials, where 6mg of ivermectin plus 400mg of albendazole has been the workhorse regimen for treating soil-transmitted helminthiases (STH) at population scale.

Ivermectin and albendazole are the two most-studied broad-spectrum antiparasitics on the WHO Model List of Essential Medicines. Individually they cover different worm species with modest overlap. Combined, they clear a broader range of infections with fewer doses.

Ivermectin (6mg component) covers strongyloidiasis, onchocerciasis, filariasis, scabies, and provides partial activity against Ascaris. It has weak activity against hookworm and essentially no activity against Trichuris (whipworm) at standard single doses.

Albendazole (400mg component) covers Ascaris (roundworm), Ancylostoma and Necator (hookworm), Enterobius (pinworm), Trichuris (whipworm), Taenia intestinal tapeworm, Strongyloides at higher doses, and provides tissue-penetrating activity for hydatid disease and neurocysticercosis at extended courses.

What the combination does that neither drug does alone: it clears whipworm at meaningfully higher single-dose cure rates than albendazole monotherapy, and it clears mixed infections (very common in returning travelers and immigrants from endemic regions) in one shorter treatment cycle.

The Evidence: Why Combination Therapy Beats Monotherapy for Mixed Infections

The strongest evidence comes from a series of randomized controlled trials led by Jennifer Keiser''s group at the Swiss Tropical and Public Health Institute, and from WHO-supported field studies in Africa and Southeast Asia.

Speich et al. Lancet Infectious Diseases 2015 compared four regimens in over 400 children with T. trichiura and other soil-transmitted helminths on Pemba Island, Tanzania. Albendazole plus ivermectin achieved 27.6% cure rate for whipworm versus 2.1% for albendazole monotherapy at 3 weeks. Egg reduction rate for whipworm was 96.8% for the combination versus 45.4% for albendazole alone. For hookworm and Ascaris, cure rates were essentially the same across arms (both drugs clear these worms very well). PMID: 25589326.

Palmeirim et al. PLoS Neglected Tropical Diseases 2018 extended these results in a multicountry setting and confirmed that ivermectin plus albendazole outperformed either drug alone specifically for whipworm cure, with acceptable tolerability at standard doses. PMID: 29851957.

Moser et al. BMJ 2017 systematic review and meta-analysis of anthelminthic trials found that against Trichuris trichiura, single-dose ivermectin plus albendazole yielded cure rates of about 38% vs 28% for albendazole alone, and against hookworm, both regimens performed similarly well (~80% cure). PMID: 28947636.

The clinical takeaway: for a patient with confirmed or highly suspected mixed helminthiasis, or specifically for whipworm coverage, the ivermectin plus albendazole combination is superior to either drug alone at single-dose schedules. That is why fixed-dose combinations like Wormentel Duo exist as a treatment option.

When Wormentel Duo Is the Right Choice

Cases where the combination makes sense:

• Returning travelers from endemic regions (Sub-Saharan Africa, South Asia, Southeast Asia, parts of Latin America) with unexplained abdominal symptoms, eosinophilia, or documented mixed helminthiasis on stool testing.
• Immigrants from areas with high soil-transmitted helminth prevalence where empirical broad-spectrum treatment is often recommended before parasite-specific testing.
• Documented whipworm infection, either isolated or as part of a mixed infection, where single-dose albendazole monotherapy has low cure rates.
• Strongyloidiasis with concurrent geohelminth exposure, where ivermectin covers Strongyloides and albendazole covers coinfections.
• Empirical broad-spectrum treatment in patients with tropical exposure and gastrointestinal symptoms when parasite-specific testing is not readily available.

Cases where the combination is not needed or not appropriate:

• Simple pinworm infection in an otherwise healthy household. Mebex 100mg single-dose mebendazole or over-the-counter pyrantel pamoate is sufficient and cheaper.
• Suspected tapeworm. Praziquantel (Biltree 600mg) is the correct drug, not the ivermectin/albendazole combination.
• Schistosomiasis. Praziquantel is first-line, not albendazole or ivermectin.
• Suspected neurocysticercosis or hydatid disease. These require extended-course tissue-penetrating albendazole under specialist supervision, not the single-dose combination.

Standard Dosing for US Adults and Children

The clinical trials that established the combination''s efficacy used a fixed adult regimen of ivermectin 200 mcg/kg plus albendazole 400mg as a single dose. For an average 70 kg adult, that maps to a single Wormentel Duo tablet (ivermectin 6mg is close to 200 mcg/kg for someone in the 60 to 80 kg range) plus the standard 400mg albendazole content.

Adults 60 to 80 kg: single tablet as one dose.

Adults over 80 kg: weight-based ivermectin dose adjustment may be indicated; consult a physician for accurate dose calculation, as a heavier patient may need supplemental ivermectin from a standalone product like Ivercor 12mg.

Adults under 60 kg: weight-based dose adjustment is prudent; consult a physician, especially if closer to the 40 to 45 kg range.

Children age 5 and older, weighing at least 15 kg: physician-supervised weight-based dosing. Ivermectin at 200 mcg/kg and albendazole at 400mg (or 200mg for children under 24 months per WHO guidance) applies, but the fixed-dose combination is typically reserved for older children and adults where the fixed doses match calculated needs.

Take with a fatty meal. Both ivermectin and albendazole absorption from the gut are increased 2 to 5-fold when taken with a meal containing fat. This matters especially for albendazole tissue penetration and for coverage of Strongyloides.

Repeat testing: stool ova and parasite testing at 3 to 4 weeks post-treatment confirms cure. For whipworm specifically, a second dose 2 to 3 weeks after the first is sometimes recommended for heavy infections.

Safety and Contraindications

Both component drugs are well tolerated at standard single-dose schedules. Common transient side effects, appearing within hours of dosing and resolving within a day or two:

• Mild abdominal discomfort
• Headache
• Dizziness
• Nausea, occasionally vomiting
• Transient pruritus or urticaria (especially in filariasis and onchocerciasis-endemic areas, driven by parasite die-off)

Contraindications: known hypersensitivity to ivermectin, albendazole, or benzimidazoles; pregnancy first trimester (both drugs are Category C in US labeling); active Loa loa filariasis with high microfilarial load (ivermectin can cause severe encephalopathic reactions, requires screening in Loa-endemic regions of Central Africa); severe hepatic impairment (albendazole is hepatotoxic at extended courses).

Cautions: breastfeeding (both drugs cross into milk; consult a physician), children under 5 or under 15 kg (dose fit is poor with fixed combinations), concurrent strong CYP450 inducers (rifampin, carbamazepine, phenytoin) which reduce albendazole levels.

Drug interactions: concurrent dexamethasone can raise albendazole plasma levels approximately 50%. Cimetidine also raises albendazole levels. Grapefruit juice can raise ivermectin levels somewhat. These interactions are rarely problematic at single-dose treatment schedules but matter in extended-course therapy for cysticercosis or hydatid disease.

How Wormentel Duo Compares to Alternatives

Wormentel Duo vs Albendazole alone (Zentel 400mg): the combination is markedly better against whipworm (27.6% vs 2.1% cure at single dose in the Speich trial) and slightly better in mixed-infection eradication. For patients with confirmed Ascaris-only or hookworm-only infection, albendazole alone is essentially as effective as the combination and is cheaper.

Wormentel Duo vs Ivermectin alone (Ivercor 12mg): the combination adds coverage for hookworm, Ascaris (albendazole is more reliably active), and whipworm, all of which ivermectin covers weakly or not at all. For pure strongyloidiasis, ivermectin alone at the standard 200 mcg/kg single dose is sufficient.

Wormentel Duo vs Ivermectin plus Fenbendazole: the ivermectin plus fenbendazole combination has become popular in some online communities under the Joe Tippens protocol, but fenbendazole is not human-approved. For treating an actual worm infection, ivermectin plus albendazole (a human-labeled, evidence-based combination) is the correct pairing. See our Ivermectin and Fenbendazole article for full context on the fenbendazole side of that discussion.

Wormentel Duo vs mebendazole: mebendazole (Mebex 100mg, Mebmox 500mg) is a solid single-agent option for simple household pinworm and roundworm. For mixed or whipworm-heavy infections, the ivermectin plus albendazole combination outperforms mebendazole in head-to-head trials.

How to Buy Wormentel Duo Online in the USA

Wormentel Duo is not FDA-approved as a fixed-dose combination product. Both component drugs individually are FDA-approved (ivermectin as Stromectol, albendazole as Albenza), and the combination has strong international evidence and WHO endorsement for mass drug administration programs.

US buyers who want the fixed-dose combination have two paths:

1. Take the components separately. A physician can prescribe Stromectol (ivermectin) and Albenza (albendazole) separately, filled at a US retail pharmacy. This works clinically but the retail cost of Albenza can exceed $200 per tablet, and the physician needs to be comfortable prescribing them together.
2. Personal-quantity import of Wormentel Duo from a WHO-GMP certified international pharmacy. This falls under FDA enforcement discretion policy for personal importation of a prescription drug not readily available at reasonable US cost. Non-controlled generic antiparasitics in personal-use quantities typically clear customs without issue.

SafeRxPills ships Wormentel Duo 156mg from Kachhela Medex''s licensed facility directly to US addresses. Personal-quantity packaging, tracking at dispatch, standard delivery in 10 to 18 business days.

Ordering Timeline for US Buyers

• Day 0: Order and payment confirmed. Confirmation email sent.
• Day 1 to 3: Dispatch from Kachhela Medex facility, Surat, India. Tracking number issued.
• Day 4 to 8: International transit visible on India Post and USPS tracking systems.
• Day 9 to 14: US customs processing. Personal quantities of non-controlled antiparasitics typically clear without issue.
• Day 12 to 20: Final-mile delivery to US address.

Bottom Line

Wormentel Duo is a fixed-dose combination of ivermectin and albendazole that solves a real clinical problem: mixed helminthiases and whipworm-containing infections that neither drug clears well alone at single-dose schedules. The combination is backed by peer-reviewed randomized trials, is on the WHO mass drug administration playbook, and provides a single-tablet treatment for patients who would otherwise need to take two prescriptions separately. It is not a general-purpose worm drug; it is a specific tool for specific patients. If you have a mixed or whipworm-heavy infection, tropical exposure history, or documented soil-transmitted helminth infection, the combination is a well-supported choice.

Order Wormentel Duo 156mg from SafeRxPills, or explore related content: Ivermectin and Fenbendazole Tablets, Zentel (Albendazole) Complete Guide, Ivermectin vs Mebendazole, or the full antiparasitic catalog.

References:

• Speich B, Ame SM, Ali SM, et al. Efficacy and safety of albendazole plus ivermectin, albendazole plus mebendazole, albendazole plus oxantel pamoate, and mebendazole alone against Trichuris trichiura and concomitant soil-transmitted helminth infections. Lancet Infect Dis. 2015;15(3):277 to 284. PMID: 25589326.
• Palmeirim MS, Hurlimann E, Knopp S, et al. Efficacy and safety of co-administered ivermectin plus albendazole for treating soil-transmitted helminths. PLoS Negl Trop Dis. 2018;12(4):e0006458. PMID: 29851957.
• Moser W, Schindler C, Keiser J. Efficacy of recommended drugs against soil transmitted helminths: systematic review and network meta-analysis. BMJ. 2017;358:j4307. PMID: 28947636.
• DailyMed. Stromectol (ivermectin) Prescribing Information. National Library of Medicine.
• DailyMed. Albenza (albendazole) Prescribing Information. National Library of Medicine.
• World Health Organization. Guideline: Preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups. WHO 2017.
• Centers for Disease Control and Prevention. Parasites - Soil-Transmitted Helminths: Resources for Health Professionals. cdc.gov